Monotherapy with GI262570, a non-thiazolidinedione PPARγ agonist, improves glycemic control in type 2 diabetes mellitus patients (T2DM)

被引：0
|
作者：
Abou-Donia, M
Fiedorek, FT
Wilson, GG
Frith, L
Patel, J
机构：
[1] Glaxo Wellcome Co, Res Triangle Pk, NC USA
[2] PPA20005 Study Grp, Greenford, Middx, England
来源：
DIABETOLOGIA | 2000年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
726
引用
收藏
页码：A189 / A189
页数：1
相关论文
共 50 条
  • [41] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [42] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [43] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [44] Rosiglitazone (RSG) is safe and well tolerated as monotherapy or combination therapy in patients with type 2 diabetes mellitus (T2DM)
    Kreider, M
    Miller, E
    Patel, J
    DIABETES, 1999, 48 : A117 - A117
  • [45] Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy
    Riedel, Aylin A.
    Heien, Herbert
    Wogen, Jenifer
    Plauschinat, Craig A.
    PHARMACOTHERAPY, 2007, 27 (08): : 1102 - 1110
  • [46] Triple-Goal Achievement in Patients with Type 2 Diabetes Mellitus (T2DM) Improves Clinical Outcomes
    Shi, Qian
    Shi, Lizheng
    Fonseca, Vivian
    DIABETES, 2015, 64 : A236 - A236
  • [47] Effect of baseline glycemic status on the efficacy of oral agents in type 2 diabetes mellitus (T2DM)
    Inzucchi, SE
    Dodis, R
    Viscoli, CM
    Holmboe, ES
    Bloomgarden, ZT
    DIABETES, 2004, 53 : A476 - A476
  • [48] Colesevelam HCl improves glycaemic control in patients with type 2 diabetes (T2DM): a pilot study
    Jones, M.
    Schwartz, S.
    Zieve, F.
    Kalin, M.
    DIABETOLOGIA, 2006, 49 : 746 - 747
  • [49] Glycaemic control and pregnancy outcomes in women with Type 2 diabetes mellitus (T2DM)
    Pang, W. H.
    Tan, Z.
    Todd, D.
    Halliday, M.
    Gill, F.
    Rhoads, M.
    Sathiskumar, P.
    Gallagher, A.
    de Chazal, R.
    Lawrence, I. G.
    DIABETIC MEDICINE, 2008, 25
  • [50] The effects of gastric electrical stimulation (TANTALUS®) on glycemic control in obese patients with type 2 diabetes (T2DM)
    Bohdjalian, Arthur
    Rosak, Ch
    Jung, R.
    Schramm, M.
    Weiner, R.
    Ludvik, B.
    Prager, G.
    OBESITY SURGERY, 2007, 17 (08) : 1055 - 1055
12345